Top Markets
Coin of the day
Levitee Labs Inc. Levitee Labs Inc.

Levitee Labs Inc.

LVT
Rang in aandelen #39733
Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019,... Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019, functions as a comprehensive wellness enterprise. The company is dedicated to delivering evidence-backed alternative medical treatments and pioneering psychedelic therapies, operating through its Medical Services and Selling Products divisions. Within its medical operations, Levitee Labs provides care and prescriptions for a range of conditions, including substance use disorders, various chronic pain conditions such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, in addition to Hepatitis-C and diverse mental health issues. This segment encompasses the management of five Levitee Clinics and three Levitee Pharmacies situated in Alberta. Furthermore, the company facilitates electronic prescriptions for addiction treatment via its BlockMD platform and distributes a selection of wholesale supplements and superfoods under the Earth Circle Organics brand. The organization adopted its current name, Levitee Labs Inc., on November 30, 2020, having previously been known as Fibonacci Capital Corp.
Aandeelprijs
$0.00366968
Laatst gesynchroniseerd: 2024-07-23
Marktkapitalisatie
$368.50K
Verandering (1 dag)
-0.91%
Verandering (1 jaar)
0.00%
Land
CA
Handel Levitee Labs Inc. (LVT)

Categorie

Winst voor Levitee Labs Inc. (LVT)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Levitee Labs Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Levitee Labs Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten